Short Interest in Quipt Home Medical Corp. (NASDAQ:QIPT) Increases By 19.3%

Quipt Home Medical Corp. (NASDAQ:QIPT) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 1,050,000 shares, a growth of 19.3% from the November 30th total of 880,100 shares. Approximately 2.7% of the company’s stock are short sold. Based on an average daily volume of 167,800 shares, the short-interest ratio is currently 6.3 days.

Quipt Home Medical Stock Up 8.9 %

QIPT stock traded up $0.25 on Tuesday, hitting $3.05. 543,839 shares of the company’s stock were exchanged, compared to its average volume of 196,083. The firm has a 50 day moving average price of $2.63 and a two-hundred day moving average price of $2.91. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.77 and a current ratio of 1.11. Quipt Home Medical has a 12-month low of $2.30 and a 12-month high of $5.26. The stock has a market cap of $131.43 million, a P/E ratio of -27.73 and a beta of 0.62.

Quipt Home Medical (NASDAQ:QIPT) last posted its earnings results on Monday, December 16th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.08). Quipt Home Medical had a negative net margin of 1.95% and a negative return on equity of 4.51%. As a group, equities research analysts expect that Quipt Home Medical will post -0.1 EPS for the current fiscal year.

Insider Buying and Selling at Quipt Home Medical

In related news, VP Patrick Dennis Gamble bought 17,000 shares of the business’s stock in a transaction on Thursday, December 26th. The shares were bought at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the completion of the purchase, the vice president now directly owns 40,057 shares of the company’s stock, valued at approximately $98,139.65. This trade represents a 73.73 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 4.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp increased its holdings in shares of Quipt Home Medical by 32.8% during the 2nd quarter. Bank of New York Mellon Corp now owns 129,738 shares of the company’s stock valued at $418,000 after purchasing an additional 32,073 shares in the last quarter. Rhumbline Advisers grew its position in Quipt Home Medical by 21.0% during the second quarter. Rhumbline Advisers now owns 49,276 shares of the company’s stock valued at $159,000 after buying an additional 8,541 shares during the period. Hsbc Holdings PLC increased its holdings in Quipt Home Medical by 10.4% in the second quarter. Hsbc Holdings PLC now owns 52,522 shares of the company’s stock valued at $165,000 after buying an additional 4,969 shares in the last quarter. ProShare Advisors LLC acquired a new position in shares of Quipt Home Medical in the second quarter worth about $35,000. Finally, SG Americas Securities LLC purchased a new stake in shares of Quipt Home Medical during the 3rd quarter worth about $44,000. 42.85% of the stock is currently owned by hedge funds and other institutional investors.

Quipt Home Medical Company Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.